<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25993599</article-id>
      <article-id pub-id-type="pmc">4415872</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20150027</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sickle-cell Anemia and Latent Diastolic Dysfunction: Echocardiographic
Alterations</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fattori</surname>
            <given-names>Andr&#xE9;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Daniela Camargo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castilho</surname>
            <given-names>Roger Frig&#xE9;rio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coelho</surname>
            <given-names>Ot&#xE1;vio Rizzi</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <aff id="aff01"> Faculdade de Ci&#xEA;ncias M&#xE9;dicas da Universidade Estadual de
Campinas &#x2013; Unicamp, S&#xE3;o Paulo, SP - Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Andr&#xE9; Fattori,</bold> Rua Joaquim de
Paula Souza, 52, Proen&#xE7;a. Postal Code: 13026-210, Campinas &#x2013; SP, Brazil.
E-mail: <email>afattori@fcm.unicamp.br</email>;
<email>afattori@unicamp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <volume>104</volume>
      <issue>4</issue>
      <fpage>e30</fpage>
      <lpage>e33</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution NonCommercial License which permits unrestricted noncommercial
use, distribution, and reproduction in any medium provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Ventricular Dysfunction</kwd>
        <kwd>Heart Rate</kwd>
        <kwd>Anemia, Sickle Cell</kwd>
        <kwd>Echocardiography, Doppler</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Sickle-cell anemia (SCA) is a disease that can cause systemic complications, such as
multiple organ dysfunction due to vaso-occlusion and endothelial activation. The genetic
cause of the disease is a substitution of the amino acid glutamic acid for valine in the
position 6 of the beta globin chain<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.
Stress factors in the vascular microenvironment (cellular dehydration, hypoxemia,
increased corpuscular hemoglobin concentration, decreased red blood cell transit time in
the microcirculation, and decreased blood pH) trigger intracellular hemoglobin
polymerization, forming paracrystalline structures that cause sickling of erythrocytes
and increased blood viscosity, hemolysis, and vaso-occlusion<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup>. Simultaneously,
free hemoglobin in the plasma sequesters nitric oxide (NO), leading to decreased NO
bioavailability and increased endothelial adhesion (in physiological conditions, NO
inhibits of platelet aggregation, platelet activation, transcription of platelet
adhesion proteins)<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.</p>
      <p>The increase in cardiac output (CO), the afterload reduction due to the peripheral
vasodilation as a response to hypoxemia, the increase in blood viscosity secondary to
the morphological alterations, and the loss of the deformability of the sickle red blood
cells are factors involved with the systolic ventricular overload and progressive
enlargement of the cardiac chambers<sup><xref rid="r03" ref-type="bibr">3</xref>-<xref rid="r05" ref-type="bibr">5</xref></sup>.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>In the present paper, we report the adverse effects after volume expansion observed in a
single patient with SCA. Initial examination showed borderline left ventricular systolic
function, without evident diastolic dysfunction on echocardiography, which was performed
as part of a study protocol for cardiac complications in adults with SCA and was
previously approved by the local ethics committee.</p>
      <p>We present the details of the case below. The patient was a 40-year-old male SCA patient
without history of symptoms except for the complaint of sporadic palpitations related to
moderate physical effort at presentation. Cardiac function was evaluated using
two-dimensional echocardiography in <italic>M</italic>-mode, pulsed wave Doppler,
continuous wave Doppler, color Doppler, and tissue Doppler<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup>. Baseline
laboratory examinations showed serum hemoglobin levels of 10.1 mg/dL, lactate
dehydrogenase (LD) levels of 1,002 U/L, ferritin levels of 280.9 ng/mL, NT-pro-BNP
levels of 250.0 pg/ml; the electrophoretic profile of hemoglobin determined by
high&#x2011;performance liquid chromatography showed 82.6% HBS and 3.8%, HA2, with the
remainder being HBF.</p>
      <p>After the initial examination, the patient underwent normal saline infusion. After 12
min of infusion (400 ml), he complained of palpitation and dyspnea. Physical examination
showed an elevated jugular venous column and pulmonary crepitations. Echocardiography
was repeated and isolated periods of supraventricular bigeminy and supraventricular
extrasystoles were observed (<xref ref-type="table" rid="t01">Table 1</xref>); these
findings persisted for up to 10 min after the infusion was stopped. When
echocardiography was repeated again after restarting intravenous normal saline infusion,
important variations were observed in chamber sizes and parameters indicating diastolic
function compared with the values obtained at baseline. The left atrium (LA), which
initially showed a small increase in volume (34.0 ml/m<sup>2</sup>), showed marked
dilatation (56.0 ml/m&#xB2;); the ejection fraction was normal, as assessed by the Teicholtz
(60%) and Simpson (54%) methods (<xref ref-type="fig" rid="f01">Figures 1</xref> and
<xref ref-type="fig" rid="f02">2</xref>).</p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Echocardiographic measures at baseline and after the volume load (400 mL of 0.9%
saline solution)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">
                <bold> Parameter</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Baseline</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Value at overload</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Aortic root diameter (cm)</td>
              <td align="center" rowspan="1" colspan="1">3.1</td>
              <td align="center" rowspan="1" colspan="1">3.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Left atrial diameter (cm)</td>
              <td align="center" rowspan="1" colspan="1">4.4</td>
              <td align="center" rowspan="1" colspan="1">4.4</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Left atrial volume (end of the ventricular systole), ml/m<sup>2</sup></td>
              <td align="center" rowspan="1" colspan="1">34.0</td>
              <td align="center" rowspan="1" colspan="1">56.0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Maximum right atrial volume (ml)</td>
              <td align="center" rowspan="1" colspan="1">44.0</td>
              <td align="center" rowspan="1" colspan="1">47.0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LV end-diastolic diameter (cm)</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LV end-systolic diameter (cm)</td>
              <td align="center" rowspan="1" colspan="1">3.8</td>
              <td align="center" rowspan="1" colspan="1">3.7</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Thickness of the interventricular septum (cm)</td>
              <td align="center" rowspan="1" colspan="1">0.80</td>
              <td align="center" rowspan="1" colspan="1">0.90</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Thickness of LV posterior wall (cm)</td>
              <td align="center" rowspan="1" colspan="1">0.80</td>
              <td align="center" rowspan="1" colspan="1">0.80</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">RV end-diastolic diameter (cm)</td>
              <td align="center" rowspan="1" colspan="1">2.4</td>
              <td align="center" rowspan="1" colspan="1">2.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Left ventricular mass (g)</td>
              <td align="center" rowspan="1" colspan="1">122</td>
              <td align="center" rowspan="1" colspan="1">142</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LEV mass/volume ratio</td>
              <td align="center" rowspan="1" colspan="1">0.80</td>
              <td align="center" rowspan="1" colspan="1">0.90</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Teichholz ejection fraction</td>
              <td align="center" rowspan="1" colspan="1">58%</td>
              <td align="center" rowspan="1" colspan="1">60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Simpson ejection fraction</td>
              <td align="center" rowspan="1" colspan="1">50%</td>
              <td align="center" rowspan="1" colspan="1">54%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mitral E/A ratio</td>
              <td align="center" rowspan="1" colspan="1">1.27</td>
              <td align="center" rowspan="1" colspan="1">2.67</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Deceleration time (ms)</td>
              <td align="center" rowspan="1" colspan="1">0.150</td>
              <td align="center" rowspan="1" colspan="1">0.217</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Isovolumic relaxation time (ms)</td>
              <td align="center" rowspan="1" colspan="1">0.046</td>
              <td align="center" rowspan="1" colspan="1">0.096</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">E wave (cm/s)</td>
              <td align="center" rowspan="1" colspan="1">86.8</td>
              <td align="center" rowspan="1" colspan="1">80.8</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">A wave (cm/s)</td>
              <td align="center" rowspan="1" colspan="1">68.5</td>
              <td align="center" rowspan="1" colspan="1">30.2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mitral/Septal S' wave (cm/s)</td>
              <td align="center" rowspan="1" colspan="1">8.70</td>
              <td align="center" rowspan="1" colspan="1">8.70</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mitral/Septal E' wave (cm/s)</td>
              <td align="center" rowspan="1" colspan="1">12.80</td>
              <td align="center" rowspan="1" colspan="1">13.40</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Septal/mitral E/E' ratio</td>
              <td align="center" rowspan="1" colspan="1">6.78</td>
              <td align="center" rowspan="1" colspan="1">6.03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Septal/mitral E'/A' ratio</td>
              <td align="center" rowspan="1" colspan="1">1.47</td>
              <td align="center" rowspan="1" colspan="1">2.4</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">TEI index</td>
              <td align="center" rowspan="1" colspan="1">0.23</td>
              <td align="center" rowspan="1" colspan="1">0.34</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Acceleration time/ejection time</td>
              <td align="center" rowspan="1" colspan="1">0.48</td>
              <td align="center" rowspan="1" colspan="1">0.47</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mitral gradient</td>
              <td align="center" rowspan="1" colspan="1">28.0</td>
              <td align="center" rowspan="1" colspan="1">25.0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Systolic flow/diastolic flow of the pulmonary vein</td>
              <td align="center" rowspan="1" colspan="1">&gt;1</td>
              <td align="center" rowspan="1" colspan="1">&lt;1</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>(A) Parasternal view in M-mode showing the aorta and the left atrium. (B) The same
view as figure A, with ECG showing isolated ventricular extrasystoles. (C)
Baseline spectral Doppler recording of the mitral flow. (D) Postinfusion spectral
Doppler recording, showing mitral reflux and the development of the L wave.</p>
        </caption>
        <graphic xlink:href="abc-104-04-0e30-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Apical views of the four chambers before (A) and after (B) volu me expansion,
showing left atrial volumes of 34 mL/m<sup>2</sup> and 56 mL/m<sup>2</sup>,
respectively.</p>
        </caption>
        <graphic xlink:href="abc-104-04-0e30-g02"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>With regard to the parameters of diastolic function analyzed in the present case, a
progression to an abnormal diastolic filling pattern was observed in the second
echocardiographic examination, as shown in <xref ref-type="table" rid="t01">Table
1</xref>. The E/A ratio showed a marked increase, compatible with an abnormal
diastolic filling pattern, as observed in type II diastolic dysfunction. These findings
were corroborated by the appearance of the L wave and the inversion of the S/D flow in
the pulmonary vein <sup><xref rid="r07" ref-type="bibr">7</xref></sup>. Other
characteristic indicators of diastolic dysfunction, such as increased isovolumic
relaxation time and E wave deceleration time, were compatible with myocardial
overload.</p>
      <p>The expected change in diastolic function during pressure overload of LA would be a
reduction of E and mitral E velocities and the maintenance of an elevated E/E&#x2019; ratio
proportional to the degree of diastolic dysfunction. In the present case, mitral flow
velocities were paradoxically decreased; however, E&#x2019; velocity increased. Thus, mitral
flow velocities were not considered to be a reliable marker of diastolic dysfunction for
this patient. The pulmonary venous flow was a more accurate marker of the alteration
from the normal pattern to an abnormal diastolic filling pattern. It is possible that
this phenomenon is related to a hyperdynamic cardiac state secondary to anemia, probably
because of increased recruitment of cardiac muscle fibers during volume overload
(evidenced by the increased E&#x2019; velocity and increased ejection fraction).</p>
      <p>An important characteristic that was also evaluated was the rate of global ventricular
performance, or the Tei index, a parameter indicated for the standardization and
comparison of results obtained by different studies. In this patient, the Tei index
increased from 0.23 to 0.34 after normal saline infusion. This worsening of performance
can be explained by the increase in the duration of isovolumic contraction and
relaxation, combined with decreased ventricular compliance. It is interesting to note
that the heart rate did not change in the observation period.</p>
      <p>The echocardiographic follow-up used independent measures of volume load because the
hemodynamic characteristics of SCA, such as increased CO, may mask diastolic
dysfunction, thus leading to the underdiagnosis of the condition. The patient described
in this case showed two biochemical markers associated with unfavorable outcomes.
Elevated LD values are indicators of marked hemolysis and predictors of clinical
complications in SCA, mainly those associated with endothelial activation and chronic
inflammation.<sup><xref rid="r08" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup> Another characteristic was the elevation in NT-pro-BNP
levels, which were at 250.0 pg/ml at baseline in the present case; this may suggest the
subclinical impairment of cardiac function. NT-pro&#x2011;BNP levels &gt;&#xA0;160.0&#xA0;pg/mL have been
associated with the diagnosis of pulmonary hypertension, and they are considered an
independent risk factor for high mortality.<sup><xref rid="r08" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The importance of this case lies in the fact that cardiopulmonary complications are the
main cause of death in SCA patients. In particular, in the present case, a normal
echocardiographic pattern was observed before volume stress. This suggests that some SCA
patients can present with potentially fatal complications even if few abnormalities are
observed at examination. Additional studies are needed to better understand the
alterations in ventricular/atrial compliance and diastolic function as well as to
identify patients at risk of hemodynamic decompensation and adverse outcomes.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="con">
        <p>
          <bold>Author contributions</bold>
        </p>
        <p>Conception and design of the research: Fattori A, Oliveira DC, Coelho OR; Acquisition
of data and Writing of the manuscript: Fattori A, Oliveira DC; Analysis and
interpretation of the data and Critical revision of the manuscript for intellectual
content: Fattori A, Oliveira DC, Castilho RF, Coelho OR; Statistical analysis and
Obtaining financing: Fattori A; Fattori A, Oliveira DC, Castilho RF, Coelho OR.</p>
      </fn>
      <fn fn-type="conflict">
        <p>
          <bold>Potential Conflict of Interest</bold>
        </p>
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>This study was funded by FAPESP.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This article is part of the thesis of Doctoral submitted by Daniela Camargo Oliveira,
from Faculdade de Ci&#xEA;ncias M&#xE9;dicas - UNICAMP.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>Reference</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kato</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Gladwin</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Steinberg</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Deconstructing sickle cell disease: reappraisal of the role of
hemolysis in the development of clinical subphenotypes</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>37</fpage>
          <lpage>47</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eaton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Hofrichter</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Sickle cell hemoglobin polymerization</article-title>
          <source>Adv Protein Chem</source>
          <year>1990</year>
          <volume>40</volume>
          <fpage>63</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">2195851</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Covitz</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Espeland</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hellenbrand</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Leff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Talner</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The heart in sickle cell anemia. The Cooperative Study of Sickle Cell
Disease (CSSCD)</article-title>
          <source>Chest</source>
          <year>1995</year>
          <volume>108</volume>
          <issue>5</issue>
          <fpage>1214</fpage>
          <lpage>1219</lpage>
          <pub-id pub-id-type="pmid">7587419</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eddine</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lipshultz</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Kardon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arheart</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Swaminathan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Ventricular structure and function in children with sickle cell
disease using conventional and tissue Doppler echocardiography</article-title>
          <source>Am J Cardiol</source>
          <year>2012</year>
          <volume>109</volume>
          <issue>9</issue>
          <fpage>1358</fpage>
          <lpage>1364</lpage>
          <pub-id pub-id-type="pmid">22341365</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martins</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Pinheiro</surname>
              <given-names>LAF</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>LJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Altera&#xE7;&#xF5;es cardiovasculares na anemia
falciforme</article-title>
          <source>Arq Bras Cardiol</source>
          <year>1998</year>
          <volume>70</volume>
          <issue>5</issue>
          <fpage>365</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">9687645</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheitlin</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Alpert</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Aurigemma</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Beller</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Bierman</surname>
              <given-names>FZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ACC/AHA guidelines for the clinical application of echocardiography. A
report of the American College of Cardiology/American Heart Association Task Force
on Practice Guidelines (Committee on Clinical Application of Echocardiography).
Developed in collaboration with the American Society of
Echocardiography</article-title>
          <source>Circulation</source>
          <year>1997</year>
          <volume>95</volume>
          <issue>6</issue>
          <fpage>1686</fpage>
          <lpage>1744</lpage>
          <pub-id pub-id-type="pmid">9118558</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagueh</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Appleton</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Gillebert</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Smiseth</surname>
              <given-names>OA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recommendations for the evaluation of left ventricular diastolic
function by echocardiography</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2009</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>107</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">19187853</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voskaridou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tsetsos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tsoutsias</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Spyropoulou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Christoulas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Terpos</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary hypertension in patients with sickle cell/beta thalassemia:
incidence and correlation with serum N-terminal pro-br92(6):738-43.ain natriuretic
peptide concentrations</article-title>
          <source>Haematologica</source>
          <year>2007</year>
          <volume>92</volume>
          <issue>6</issue>
          <fpage>73</fpage>
          <lpage>43</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takatsuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ivy</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Nuss</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Correlation of N-terminal fragment of B-type natriuretic peptide
levels with clinical, laboratory, and echocardiographic abnormalities in children
with sickle cell disease</article-title>
          <source>J Pediatr</source>
          <year>2012</year>
          <volume>160</volume>
          <issue>3</issue>
          <fpage>428</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="pmid">22048047</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aliyu</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Suleiman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Attah</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mamman</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Babadoko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nouraie</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia
in Africa</article-title>
          <source>Br J Haematol</source>
          <year>2010</year>
          <volume>150</volume>
          <issue>1</issue>
          <fpage>102</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">20408845</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
